Brii Biosciences Limited
Research Brii Biosciences Limited (7SS) on Bullrun: market cap EUR 69.95M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker7SS
- ExchangeF
- CountryChina
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 69.95M
- Financial periodFY2025
- RevenueCNY 18.61M
- Net income-CNY 222.62M
- Free cash flow-CNY 465.80M
Valuation Snapshot
latest market cap is EUR 69.95M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 18.61M | -CNY 222.62M | -CNY 465.80M | n/a | -0.31 | CNY 606.84M | CNY 8.93M | CNY 2.38B |
| FY2024 | CNY 0 | -CNY 508.16M | -CNY 376.12M | n/a | -0.7 | CNY 1.00B | CNY 28.02M | CNY 2.66B |
| FY2023 | CNY 617.00K | -CNY 174.83M | -CNY 643.62M | n/a | -0.24 | CNY 489.65M | CNY 3.16M | CNY 3.12B |
| FY2022 | CNY 51.63M | -CNY 484.31M | -CNY 635.57M | n/a | -0.67 | CNY 1.19B | CNY 12.66M | CNY 3.19B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-14 | EUR 69.95M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Brii Biosciences Limited
Brii Biosciences Limited focuses on developing therapies for the treatment of infectious and central nervous system diseases in China and the United States. The company develops BRII-179, a recombinant protein-based HBV immunotherapeutic candidate; Elebsiran, an investigational subcutaneously administered HBV-targeting siRNA; and Tobevibart, an investigational subcutaneously administered HBV-neutralizing monoclonal antibody which are in Phase 2 of the development stage for functional cure of HBV for Hepatitis B;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Brii Biosciences Limited's market cap?
Brii Biosciences Limited's market capitalization is EUR 69.95M.
What does Brii Biosciences Limited do?
Brii Biosciences Limited focuses on developing therapies for the treatment of infectious and central nervous system diseases in China and the United States.